Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of diabetes mellitus on outcomes in Japanese patients undergoing coronary artery bypass grafting.
Minakata K, Bando K, Takanashi S, Konishi H, Miyamoto Y, Ueshima K, Sato T, Ueda Y, Okita Y, Masuda I, Okabayashi H, Yaku H, Yasuno S, Muranaka H, Kasahara M, Miyata S, Okamura Y, Nasu M, Tanemoto K, Arinaga K, Hisashi Y, Sakata R; JMAP Study Investigators. Minakata K, et al. Among authors: kasahara m. J Cardiol. 2012 May;59(3):275-84. doi: 10.1016/j.jjcc.2011.12.009. Epub 2012 Mar 27. J Cardiol. 2012. PMID: 22459591 Free article.
Effects of renin-angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis.
Nakao YM, Teramukai S, Tanaka S, Yasuno S, Fujimoto A, Kasahara M, Ueshima K, Nakao K, Hinotsu S, Nakao K, Kawakami K. Nakao YM, et al. Among authors: kasahara m. Diabetes Res Clin Pract. 2012 Apr;96(1):68-75. doi: 10.1016/j.diabres.2011.11.025. Epub 2011 Dec 23. Diabetes Res Clin Pract. 2012. PMID: 22197527 Review.
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial.
Ueshima K, Kasahara M, Koya D, Babazono T, Sato T, Imamoto M, Yasuno S, Fujimoto A, Tanaka S, Kimura G, Nakao K. Ueshima K, et al. Among authors: kasahara m. Clin Exp Nephrol. 2013 Apr;17(2):211-7. doi: 10.1007/s10157-012-0676-5. Epub 2012 Sep 6. Clin Exp Nephrol. 2013. PMID: 22948416 Clinical Trial.
Intra-abdominal fat area is a predictor for new onset of individual components of metabolic syndrome: MEtabolic syndRome and abdominaL ObesiTy (MERLOT study).
Nakao YM, Miyawaki T, Yasuno S, Nakao K, Tanaka S, Ida M, Hirata M, Kasahara M, Hosoda K, Ueshima K, Nakao K. Nakao YM, et al. Among authors: kasahara m. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(8):454-61. doi: 10.2183/pjab.88.454. Proc Jpn Acad Ser B Phys Biol Sci. 2012. PMID: 23060233 Free PMC article.
Do statins play a role in renoprotection?
Kasahara M, Nakagawa T, Yokoi H, Kuwabara T, Yasuno S, Mori K, Mukoyama M, Ueshima K. Kasahara M, et al. Clin Exp Nephrol. 2014 Apr;18(2):282-5. doi: 10.1007/s10157-013-0928-z. Epub 2014 Jan 10. Clin Exp Nephrol. 2014. PMID: 24408222 Review.
Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases.
Kuwabara T, Mori K, Kasahara M, Yokoi H, Imamaki H, Ishii A, Koga K, Sugawara A, Yasuno S, Ueshima K, Morikawa T, Konishi Y, Imanishi M, Nishiyama A, Nakao K, Mukoyama M. Kuwabara T, et al. Among authors: kasahara m. PLoS One. 2014 Feb 18;9(2):e88942. doi: 10.1371/journal.pone.0088942. eCollection 2014. PLoS One. 2014. PMID: 24558454 Free PMC article.
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.
Kimura G, Kasahara M, Ueshima K, Tanaka S, Yasuno S, Fujimoto A, Sato T, Imamoto M, Kosugi S, Nakao K. Kimura G, et al. Among authors: kasahara m. Clin Exp Nephrol. 2017 Jun;21(3):417-424. doi: 10.1007/s10157-016-1304-6. Epub 2016 Jul 8. Clin Exp Nephrol. 2017. PMID: 27392909 Free PMC article. Clinical Trial.
Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial.
Son C, Kasahara M, Tanaka T, Satoh-Asahara N, Kusakabe T, Nishimura K, Miyamoto Y, Kasama S, Hosoda K. Son C, et al. Among authors: kasahara m. Diabetes Ther. 2020 Jan;11(1):347-358. doi: 10.1007/s13300-019-00717-9. Epub 2019 Nov 1. Diabetes Ther. 2020. PMID: 31677134 Free PMC article.
Rationale and Design of the CANONICAL Study　- Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Canagliflozin for Heart Failure With Preserved Ejection Fraction With Type 2 Diabetes Mellitus.
Kasama S, Masuyama T, Uemura S, Sato Y, Hiramitsu S, Masuda I, Yamamoto K, Komatsu S, Anzai T, Nishimura K, Ueda T, Kasahara M, Tanaka H, Susuta Y, Saito Y. Kasama S, et al. Among authors: kasahara m. Circ Rep. 2019 Aug 3;1(8):347-351. doi: 10.1253/circrep.CR-19-0049. Circ Rep. 2019. PMID: 33693161 Free PMC article.
1,228 results